Vanberra Signal

Eularis

Curated by Signal

AI based marketing and analytics platform for pharma

Overview

Eularis provides marketing analytics to the pharmaceutical market. It provides artificial intelligence based platform called E-VAI which uses proprietary machine learning algorithms to provide market data based actionable insights for sales/marketing, drug launch/pricing, market access etc. Eularis enlists Boehringer-Ingelheim, Merck, Pfizer, Roche as some of its clients.

Key facts

Founded
2003

Business model

More on Vanberra Signal

Members only
  • AI driven content marketing platform

    Enterprise Software & InfrastructureLos Angeles, United States
  • Provider of cloud based contact center and experience management platform

    Enterprise Software & InfrastructureCincinnati, United States
  • Offering cyber risk and vulnerability assessment solution

    Enterprise Software & InfrastructureCambridge, United States

About Eularis

What does Eularis do?

Eularis provides marketing analytics to the pharmaceutical market.

Where is Eularis headquartered?

Eularis is headquartered in New York City, United States.

When was Eularis founded?

Eularis was founded in 2003.

Which sector is Eularis in?

Eularis operates in Enterprise Software & Infrastructure.

Who are Eularis's competitors?

Companies similar to Eularis include Composer, Convergys, and Ceritas.